NHL reaches out to Robin Lehner after social media comments on medications, Eichel

Sports
Leafs Sabres Hockey_1530656058772

Buffalo Sabres goalie Robin Lehner (40) watches the puck during the first period of an NHL hockey game against the Toronto Maple Leafs, Thursday, March 15, 2018, in Buffalo, N.Y. (AP Photo/Jeffrey T. Barnes)

The NHL has reached out out to Robin Lehner to set up an interview after the goaltender made several accusations on social media, including that teams give players drugs without a doctor’s consent, a league spokesman confirmed to The Associated Press.

In a series of tweets Saturday, Lehner said he knows “many” teams that give sedatives and anxiety pills to players without a doctor’s prescription. He referenced the Philadelphia Flyers and coach Alain Vigneault and claimed to have proof.

In a statement Sunday, Flyers general manager Chuck Fletcher denied that allegation.

“The health and well-being of our players is our top priority, and any care provided to them comes from the team’s health care professionals, not the coaching staff,” Fletcher said. “We have no reason to believe any of our players have received improper care.”

Deputy Commissioner Bill Daly on Sunday morning said the league intended to speak with Lehner about his tweets. The league did not initially have plans to launch an independent investigation until the conversation with Lehner happens.

Lehner also accused the Buffalo Sabres of mismanaging an ankle injury when he played for them. His comments appeared to be related to the stalemate between Buffalo and now former captain Jack Eichel over how to treat a herniated disk.

The Sabres did not respond to a message seeking comment.

Lehner tweeted at the league and Players’ Association that they know how to reach him.

The 30-year-old Swede who plays for Vegas said the Golden Knights do not give players those drugs without doctor’s orders. He implied he’s prepared to share more information from around the league.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Now